Action ASND ASCENDIS PHARMA A/S
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Ascendis Pharma A/S

Actions

ASND

US04351P1012

Temps réel estimé Cboe BZX
Autres places de cotation
 21:58:19 01/05/2024 		Varia. 5j. Varia. 1 janv.
141,1 USD +1,93% Graphique intraday de Ascendis Pharma A/S -1,17% +12,35%
29/04 Les actions européennes négociées aux États-Unis sous forme de certificats de dépôt américains sont en légère hausse lundi matin MT
26/04 Les actions européennes négociées aux États-Unis sous forme de certificats de dépôt américains sont en hausse vendredi et terminent la semaine en hausse de 3,4%. MT

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Monday Trading
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.4%
Ascendis Pharma to Report First Quarter 2024 Financial Results and Provide Business Update on May 2, 2024
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading
Ascendis Pharma - United Kingdom's MHRA Approves YORVIPATH in Great Britain for the Treatment of Adults with Chronic Hypoparathyroidism
Ascendis Pharma Gets UK Regulator's Approval for Yorvipath to Treat Hypoparathyroidism
United Kingdom’s MHRA Approves YORVIPATH® (palopegteriparatide) in Great Britain for the Treatment of Adults with Chronic Hypoparathyroidism
Ascendis Pharma A/S Announces United Kingdom's MHRA Approves YORVIPATH® (palopegteriparatide) in Great Britain for the Treatment of Adults with Chronic Hypoparathyroidism
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down
European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading
Ascendis Pharma A/S : Form 6-K
European Equities Traded in the US as American Depositary Receipts Slightly Higher Thursday
Ascendis Pharma A/S : Form 6-K
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading
Ascendis Pharma A/S : Form 6-K
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Wednesday Trading
European Equities Traded in the US as American Depositary Receipts Trend Higher in Tuesday Trading
Ascendis Pharma to Participate in the Leerink Partners Global Biopharma Conference 2024
Ascendis Pharma A/S Appoints Mads Bodenhoff as Senior Vice President, Finance Principal Accounting Officer
European Equities Traded in the US as American Depositary Receipts Set to End Week Higher in Friday Trading
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action ASND
  4. Actualités Ascendis Pharma A/S
  5. Autres langues